JP2000001439A - 新生或いは非新生の抗炎症性および鎮痛効果を有する製薬学的組成物及びその製造方法 - Google Patents

新生或いは非新生の抗炎症性および鎮痛効果を有する製薬学的組成物及びその製造方法

Info

Publication number
JP2000001439A
JP2000001439A JP11118238A JP11823899A JP2000001439A JP 2000001439 A JP2000001439 A JP 2000001439A JP 11118238 A JP11118238 A JP 11118238A JP 11823899 A JP11823899 A JP 11823899A JP 2000001439 A JP2000001439 A JP 2000001439A
Authority
JP
Japan
Prior art keywords
group
cys
lys
hydrogen
tyr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11118238A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000001439A5 (enExample
Inventor
Gyorgy Dr Keri
ケーリ ヂェルヂ
Janos Dr Szolcsanyi
ソルチャーニィ ヤーノシュ
Erika Dr Pinter
ピンテール エリカ
Zsuzsanna Dr Helyes
ヘリエシュ ジュジャンナ
Judit Dr Erchegyi
エールツェヂィ ユディト
Aniko Horvath
ホルヴァート アニコー
Judit Horvath
ホルヴァート ユディト
Istvan Teplan
テプラーン イシュトヴァーン
Laszlo Oerfi
エールフィ ラースロー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOSTATIN GYOGYSZERKUTATO FEJLESZTOE KFT
Original Assignee
BIOSTATIN GYOGYSZERKUTATO FEJLESZTOE KFT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOSTATIN GYOGYSZERKUTATO FEJLESZTOE KFT filed Critical BIOSTATIN GYOGYSZERKUTATO FEJLESZTOE KFT
Publication of JP2000001439A publication Critical patent/JP2000001439A/ja
Publication of JP2000001439A5 publication Critical patent/JP2000001439A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP11118238A 1998-04-27 1999-04-26 新生或いは非新生の抗炎症性および鎮痛効果を有する製薬学的組成物及びその製造方法 Pending JP2000001439A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9800970A HU226567B1 (en) 1998-04-27 1998-04-27 Use of phenylhydrazon derivates for the preparation of medicaments for the inhibition of neurogenic and non-neurogenic inflammations and for the alleviation of pain
HU9800970 1998-04-27

Publications (2)

Publication Number Publication Date
JP2000001439A true JP2000001439A (ja) 2000-01-07
JP2000001439A5 JP2000001439A5 (enExample) 2006-05-18

Family

ID=89996480

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11118238A Pending JP2000001439A (ja) 1998-04-27 1999-04-26 新生或いは非新生の抗炎症性および鎮痛効果を有する製薬学的組成物及びその製造方法

Country Status (10)

Country Link
US (1) US6689813B2 (enExample)
EP (1) EP0952159B1 (enExample)
JP (1) JP2000001439A (enExample)
KR (1) KR19990083438A (enExample)
AT (1) ATE307145T1 (enExample)
CA (1) CA2269995A1 (enExample)
DE (1) DE69927735T2 (enExample)
DK (1) DK0952159T3 (enExample)
ES (1) ES2251803T3 (enExample)
HU (1) HU226567B1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353072A1 (en) * 1998-12-14 2000-06-22 Palatin Technologies, Inc. Metallopeptide combinatorial libraries and applications
US7049398B1 (en) * 1999-08-12 2006-05-23 Palatin Technologies, Inc. Melanocortin metallopeptide constructs, combinatorial libraries and applications
AU1623801A (en) * 1999-11-19 2001-05-30 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
US7385025B2 (en) * 2000-12-19 2008-06-10 Palatin Technologies, Inc. Metallopeptide compounds
AU2002238106A1 (en) * 2001-02-13 2002-08-28 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
US20040106548A1 (en) * 2001-09-07 2004-06-03 Schmidt Michelle A Conformationally constrained labeled peptides for imaging and therapy
CA2561560A1 (en) 2004-03-30 2005-10-13 The Regents Of The University Of California Hydrazide-containing cftr inhibitor compounds and uses thereof
WO2008079897A2 (en) 2006-12-22 2008-07-03 The Regents Of The University Of California Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
BRPI0809498A2 (pt) 2007-04-02 2014-09-23 Inst Oneworld Health Compostos inibidores de cftr e seus usos
US8207205B2 (en) 2008-04-21 2012-06-26 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
WO2009131951A2 (en) 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
US8343976B2 (en) 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
DE202012002243U1 (de) 2012-03-02 2012-04-27 Wilhelm Bilstein Gmbh & Co. Kg Messerhalter für Kreismesser

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5480870A (en) * 1991-01-25 1996-01-02 Biosignal Kutato-Fejlesztokft Tumor growth-inhibiting somatostatin analogues, pharmaceutical compositions containing them and process for preparing same
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3894083A (en) * 1972-09-21 1975-07-08 Sandoz Ltd Amides
DE3409415A1 (de) * 1984-03-14 1985-09-26 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Arzneimittel, insbesondere gegen entzuendungen
US5888765A (en) * 1995-06-23 1999-03-30 President And Fellows Of Harvard College Endothelial-cell specific promoter

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5480870A (en) * 1991-01-25 1996-01-02 Biosignal Kutato-Fejlesztokft Tumor growth-inhibiting somatostatin analogues, pharmaceutical compositions containing them and process for preparing same
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN7010002258, Ｈｅｌｙｅｓ， Ｚ． ｅｔ ａｌ．, Ｎｅｕｒｏｌｏｇｙ, 1996, Ｖｏｌ．４, ｐｐ．１１５−１１７ *

Also Published As

Publication number Publication date
HUP9800970A3 (en) 2000-04-28
US20010009899A1 (en) 2001-07-26
KR19990083438A (ko) 1999-11-25
DE69927735D1 (de) 2006-03-02
EP0952159A2 (en) 1999-10-27
US6689813B2 (en) 2004-02-10
EP0952159A3 (en) 2000-08-09
ATE307145T1 (de) 2005-11-15
CA2269995A1 (en) 1999-10-27
HU9800970D0 (en) 1998-06-29
DK0952159T3 (da) 2006-03-06
HU226567B1 (en) 2009-04-28
HUP9800970A2 (hu) 2000-02-28
DE69927735T2 (de) 2006-07-20
ES2251803T3 (es) 2006-05-01
EP0952159B1 (en) 2005-10-19

Similar Documents

Publication Publication Date Title
Satyanarayana Capsaicin and gastric ulcers
Lee et al. Afferent properties and reflex functions of bronchopulmonary C-fibers
Westerink et al. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain
Bogdanski et al. Pharmacological studies with the serotonin precursor, 5-hydroxytryptophan
KR20030060771A (ko) 국소용 마취제/아편양약물 제제 및 이들의 용도
Thán et al. Systemic anti-inflammatory effect of somatostatin released from capsaicin-sensitive vagal and sciatic sensory fibres of the rat and guinea-pig
JP2000001439A (ja) 新生或いは非新生の抗炎症性および鎮痛効果を有する製薬学的組成物及びその製造方法
TW201103531A (en) Compositions for treating drug addiction and improving addiction-related behavior
Nylander et al. Vagal influence on gastroduodenal HCO3-secretion in the cat in vivo
Lundblad et al. Effects of nasal capsaicin pretreatment and cryosurgery on sneezing reflexes, neurogenic plasma extravasation, sensory and sympathetic neurons
Bjorling et al. Neurogenic Inflammation of Guinea‐Pig Bladder
Fändriks Sympatho‐adrenergic inhibition of vagaliy induced gastric motility and gastroduodenal HCO3‐secretion in the cat
US20100204313A1 (en) Modulation of nerve pain activity by resiniferatoxin and uses thereof
CN115745890B (zh) 一种酯键化合物及其制备方法和应用、镇痛药物
Salam Modulation of inflammatory paw oedema by cysteamine in the rat
Nurko et al. Role of neuropeptide Y in opossum internal anal sphincter
Raybould et al. Serotonin and the afferent innervation of the gastrointestinal tract
Tonoue Stimulation by thyrotropin-releasing hormone of vagal outflow to the thyroid gland
JP6698358B2 (ja) 汗分泌促進剤及び該汗分泌促進剤を含有するドライスキンの予防薬又は治療薬
Bertaccini et al. Effects of physalaemin on some exocrine secretions of dogs and rats
US20080064725A1 (en) Intrathecal administration of triptan compositions to treat non-migraine pain
Zittel et al. Serotonin receptor blockade increases food intake and body weight after total gastrectomy in rats
Mok et al. The actions of dopamine on the blood pressure and heart rate of conscious hypertensive rats: evidence for reduced dopaminergic activity in rats of the Japanese strains
Grøndahl et al. Neuronal involvement in the effect of an antisecretory factor-derived peptide on induced secretion in the porcine small intestine
CN117883460A (zh) 一种紫草氰苷的用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060316

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060316

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20081001

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20081111

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20081128

A072 Dismissal of procedure [no reply to invitation to correct request for examination]

Free format text: JAPANESE INTERMEDIATE CODE: A073

Effective date: 20090519

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090527

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090826

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090831

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100728

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101027

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101101

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110407